Erika Molina is the Founder & CEO of Bioptamers. Prior to establishing Bioptamers, Erika gained experience as a Doctoral Student at the University of Bonn and Leipzig University, focusing on regenerative medicine and biopharmaceutical production. Erika also worked as a Scientific Researcher at Cell and Molecular Therapy Center and CellProtect Biotechnology, contributing to research on biopharmaceuticals and diabetes therapy. Erika holds a PhD in Biochemistry, an MSc in Biotechnology, and a Bachelor's degree in Biological Sciences.
Sign up to view 2 direct reports
Get started